A new engineered bacterial strain overcomes natural production limits of doxorubicin, producing 180% more therapy than ...
We have harnessed rational strain engineering to pave the way for cost-effective manufacturing that can meet growing global ...
An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent. The study identifies and resolves molecular "bottlenecks" that have ...
Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Hematopoietic Growth Factor PIXY321 After Moderate-Dose Fluorouracil, Doxorubicin, and Cyclophosphamide in Stage II and III Breast ...
PURPOSE: This multicenter phase II trial investigated the efficacy and toxicity of a combination of the novel intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl ...
LONDON & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces that the ...
A common chemotherapy drug used to treat Hodgkin lymphoma conferred a significantly increased risk of breast cancer among women treated during adolescence and adulthood, a large retrospective study ...
What Are The Drugs, Timetable And Possible Side Effects Expected With The TAC Chemotherapy Protocol?
Dr. Clifford Hudis answers the question: 'What Is The TAC Protocol For Chemo? — -- Question: What Are The Drugs, Timetable And Possible Side Effects Expected With The TAC Chemotherapy Protocol?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results